1001 S Main Street STE 500 Kalispell, MT
24/7 Urgent Call: +1-406-2251570

Dermatology Billing: Biopsy, Shave, Destruction, Excision, and Mohs Surgery Codes

21 min read Medical Billing 2026 Guide
A flat illustration of a dermatologist examining skin lesions beside a biopsy tray, a cryotherapy canister and a claim form, no text in the image

Direct answer: Dermatology billing turns on four facts in the note: the technique the physician used, the number of lesions treated, whether each lesion was benign, premalignant or malignant, and the size of the lesion measured before removal. Biopsy codes are chosen by technique, with tangential, punch and incisional each carrying a primary code and an add-on code. Shave removal and excision codes are chosen by anatomic site and by size, and the excision size is the lesion plus the narrowest margins, measured before the cut. Destruction codes for premalignant and benign lesions are chosen by lesion count, and destruction of malignant lesions by site and size. Mohs surgery is coded by stage and by tissue block, with the pathology work included in the Mohs code and never billed separately. The bundling rules decide what can be billed together: only one removal code per lesion, a biopsy of the same lesion is included in its removal, and a same-day visit needs modifier 25 and a separately identifiable reason.

THE FOUR FACTS THAT DECIDE THE CODE

Every dermatology procedure code is decided by the same four facts. First, the technique: was the lesion sampled with a tangential shave, a punch, or an incisional biopsy, shaved off entirely, destroyed in place, or excised with margins. Second, the number of lesions: biopsy add-ons, destruction codes and skin tag codes all count lesions, and the count decides whether an add-on or a standalone code applies. Third, the status of the lesion, benign, premalignant or malignant, because benign and malignant excisions live in different code families, and premalignant destruction has its own family that benign destruction does not share. Fourth, the size, measured before removal, because shave, excision and malignant destruction codes are all chosen by size bands. Size must be measured before the cut, not after, because tissue shrinks in formalin and a post-removal measurement can drop the lesion into a smaller size band and underpay the claim. A note that records all four facts for every lesion gives the coder everything needed, and a note that records only the procedure name does not.

THE CODE-FAMILY MAP

Dermatology procedures fall into six families, each running on a different variable, as the table below shows.

FamilyCode rangeWhat decides the code
Skin biopsy11102 to 11107Technique: tangential, punch or incisional, plus add-on codes for additional lesions
Shave removal11300 to 11313Anatomic site and lesion diameter
Destruction, premalignant17000, 17003, 17004Number of lesions treated
Destruction, benign17110, 17111Number of lesions treated
Destruction, malignant17260 to 17286Anatomic site and lesion size
Excision, benign11400 to 11446Anatomic site and excised diameter
Excision, malignant11600 to 11646Anatomic site and excised diameter
Mohs micrographic surgery17311 to 17315Anatomic site, stage and tissue blocks
Office visits99202 to 99205, 99212 to 99215Medical decision making or time

SKIN BIOPSY CODES 11102 TO 11107, TECHNIQUE DECIDES

Biopsy coding is selected by the technique the physician used, not by body site and not by what the pathologist later found. There are three primary codes, one per technique, each with a matching add-on code for additional lesions.

CodeTechniqueWhat it reports
11102Tangential, including shave, scoop, saucerization and curetteSingle lesion, first tangential biopsy
11103Tangential add-onEach additional tangential biopsy lesion
11104PunchSingle lesion, first punch biopsy
11105Punch add-onEach additional punch biopsy lesion
11106IncisionalSingle lesion, first incisional biopsy
11107Incisional add-onEach additional incisional biopsy lesion

The add-on codes are for separate lesions only, never for multiple samples from the same lesion, and each lesion needs its own documentation of number, size, anatomic location and technique. Biopsy codes include simple closure when performed, so do not bill a separate repair code for closing a biopsy site, and they carry a 0-day global period. When more than one biopsy technique is used on the same date, only one primary code is reported, plus add-on codes for the additional lesions, and the primary code goes to the highest-ranked technique performed: incisional if one was performed, or punch if no incisional was performed, with tangential last. For example, a punch biopsy of one lesion and tangential biopsies of two other lesions on the same date are reported as one 11104 plus two units of 11103. Do not report a primary code for each technique, because that overstates the service.

SHAVE REMOVAL CODES 11300 TO 11313

A shave removal takes a benign lesion off completely for therapeutic reasons, which is different from a tangential biopsy that only samples it, even though the blade technique looks similar. Intent decides the code: sampling is a biopsy, complete removal is a shave removal, and shave removal codes are chosen by anatomic site and by lesion diameter, measured before removal.

Code rangeAnatomic site
11300 to 11302Trunk, arms and legs
11305 to 11307Scalp, neck, hands, feet and genitalia
11310 to 11313Face, ears, eyelids, nose, lips and mucous membrane

Within each site group the code is chosen by the lesion diameter bands, and shave removals carry a 0-day global period. Skin tags are reported separately with 11200 for the first 15 lesions and add-on code 11201 for each additional 10 lesions, with a 10-day global period. A shave removal of a lesion that is later found to be malignant does not change the code after the fact, because the code reports what the physician did and intended, not what the pathology report later showed, but a lesion known or strongly suspected to be malignant is usually excised rather than shaved.

DESTRUCTION CODES, COUNT FOR PREMALIGNANT AND BENIGN, SIZE FOR MALIGNANT

Destruction covers cryotherapy with liquid nitrogen, electrosurgery, laser ablation, chemosurgery and surgical curettement, and the note must name the method used, because the code descriptor lists the acceptable methods. For premalignant lesions such as actinic keratoses, the codes run on lesion count. Code 17000 reports the destruction of the first premalignant lesion, add-on code 17003 reports each additional lesion from the second through the fourteenth, and code 17004 is reported alone, with no 17000 and no 17003, when 15 or more are destroyed in one session. For benign lesions such as warts and molluscum, code 17110 reports the destruction of up to 14 lesions, and code 17111 reports 15 or more. Destruction of malignant lesions is different: codes 17260 to 17286 are chosen by anatomic site and by lesion size, in the same three site groups used for excisions. Destruction codes carry a 10-day global period. When both premalignant and benign lesions are destroyed in the same visit, the two families are reported together with a modifier to override the bundling edit, as covered in the modifiers section below.

CodeWhat it reports
17000Destruction of the first premalignant lesion, such as an actinic keratosis
17003Each additional premalignant lesion, second through fourteenth, add-on
17004Destruction of 15 or more premalignant lesions, reported alone
17110Destruction of up to 14 benign lesions
17111Destruction of 15 or more benign lesions
17260 to 17286Destruction of a malignant lesion, by site and size

EXCISION CODES 11400 TO 11646, SIZE PLUS MARGINS, MEASURED BEFORE THE CUT

Excision removes the whole lesion with margins through the full thickness of the skin, and the code is chosen by three things in order: whether the lesion is benign or malignant, the anatomic site group, and the excised diameter. Benign excisions use 11400 to 11446 and malignant excisions use 11600 to 11646, in the same three site groups used elsewhere. Within each site group the code is chosen by the excised diameter bands, from 0.5 cm or less up to over 4.0 cm.

Code rangeLesion typeAnatomic site
11400 to 11406BenignTrunk, arms and legs
11420 to 11426BenignScalp, neck, hands, feet and genitalia
11440 to 11446BenignFace, ears, eyelids, nose, lips and mucous membrane
11600 to 11606MalignantTrunk, arms and legs
11620 to 11626MalignantScalp, neck, hands, feet and genitalia
11640 to 11646MalignantFace, ears, eyelids, nose, lips and mucous membrane

The excised diameter is the greatest clinical diameter of the lesion plus twice the narrowest margin, measured before the excision, because the margin is taken on both sides. A 1.2 cm lesion excised with 0.3 cm margins on each side has an excised diameter of 1.8 cm, not 1.2 cm, and that measurement decides the size band. When the pathology report changes the status of the lesion, the excision code follows the confirmed diagnosis. Excision codes carry a 10-day global period. Simple repair is included in the lesion removal codes, so a simple closure is not billed separately. An intermediate or complex repair is separately reportable when the documentation supports it, because a repair that does not clear the complexity bar is bundled into the excision.

THE ONE-REMOVAL-CODE-PER-LESION RULE AND THE BIOPSY THAT DISAPPEARS

Only one removal code may be reported per lesion. Destruction, shave removal and excision are alternative methods of removing a lesion, and when a removal starts by one method and is completed by another, only the completed method is reported. A biopsy of the same lesion at the same encounter is included in the removal code, so a biopsy with an excision of the same lesion is reported as the excision only, and a biopsy with a destruction of the same lesion is reported as the destruction only, under the Medicare National Correct Coding Initiative Policy Manual, chapter III, sections E.1 to E.2, revised 1 January 2026. A biopsy is separately reportable only when it is of a different lesion from the one removed. The rule is easy to get wrong in a busy clinic, because the biopsy and the removal are both real work on the same visit, but the payer treats sampling a lesion that is then removed in the same encounter as part of the removal itself. Before the claim goes out, list every lesion, name the one code that removes or samples it, and delete any second removal code or same-lesion biopsy code. Different lesions are different lines, and the note must identify each lesion separately.

MOHS MICROGRAPHIC SURGERY 17311 TO 17315

Mohs surgery removes skin cancer in stages, with the surgeon examining each stage under the microscope before deciding whether another stage is needed, and the coding is stage-based, not size-based. The first stage is reported with the base code for the site group, each additional stage is reported with the matching additional-stage code, and each additional tissue block beyond the first five blocks in any stage is reported with the add-on code.

CodeWhat it reports
17311Mohs surgery, first stage, up to 5 tissue blocks, head, neck, hands, feet, genitalia, or any location involving muscle, cartilage, bone, tendon, major nerves or vessels
17312Mohs surgery, each additional stage, up to 5 tissue blocks, same sites as 17311
17313Mohs surgery, first stage, up to 5 tissue blocks, trunk, arms or legs
17314Mohs surgery, each additional stage, up to 5 tissue blocks, trunk, arms or legs
17315Each additional tissue block after the first 5, any stage, add-on

The Mohs code includes the removal of the tumor, the mapping and color coding of specimens, the microscopic examination by the surgeon, and the histopathologic preparation including routine stains, so the surgeon who performs Mohs never bills a separate pathology code for the same tissue. A separate pathology code such as 88305 is reported only when a different physician examines the tissue. Mohs codes carry a 0-day global period and are exempt from modifier 51, so multiple Mohs stages are not reduced by the standard multiple procedure rule. The note must show the site, the stages, the tissue blocks per stage, and the microscopic findings that justified each additional stage.

MEDICAL VERSUS COSMETIC, THE LINE THAT DECIDES PAYMENT

The same procedure can be covered or patient-pay depending on why it was done, and the reason must be in the note. Removal is medical when the lesion is symptomatic, inflamed, bleeding, irritated by clothing, growing, changing, or suspicious for malignancy, and the note documents the symptom and the clinical finding. Removal is cosmetic when the only reason is appearance, and cosmetic removal is patient-pay, with no claim submitted to the payer for the procedure itself. The distinction matters most for benign lesions, skin tags, seborrheic keratoses and warts, because the procedure is identical either way and only the documented reason changes the payment. A note that says only that a lesion was removed, with no symptom, no irritation and no suspicion recorded, reads as cosmetic to the payer. For each lesion, record the diagnosis that supports medical necessity and the facts that support it: the symptom, the size, the location, the change over time, and the examination finding. When a visit mixes medical and cosmetic removals, the medical lesions are billed and the cosmetic lesions are charged to the patient, and the note and the claim must keep the two groups separate.

THE E/M LAYER, MODIFIER 25, G2211 AND THE 2027 CHANGE COMING

Office visits in dermatology use 99202 to 99205 for new patients and 99212 to 99215 for established patients, leveled by medical decision making or by total time. A same-day visit is billed alongside a procedure only when the visit is significant and separately identifiable from the procedure itself, and that is what modifier 25 reports. Discussion of the procedure, the consent, and routine post-procedure instructions are part of the procedure and do not support modifier 25 on their own. The visit needs its own documented work, such as evaluating a separate problem or managing a chronic skin condition that is not the lesion being removed. For more on how modifier 25 is appealed when it is denied, see Modifier 25 Denial Appeal. Medicare also pays add-on code G2211 for the visit complexity of ongoing longitudinal care of a serious or complex condition, and CMS guidance is that G2211 is not reported on a visit that carries modifier 25. A change already final for next year: the calendar year 2027 Medicare Physician Fee Schedule final rule, released 4 November 2026, reduces payment for the lower-valued service when an office visit with modifier 25 is billed on the same day as a procedure with a 0-day global period, effective 1 January 2027, and dermatology is among the specialties affected, because biopsies, shave removals and Mohs all carry 0-day globals. The 2026 rule is unchanged, but a practice that bills many same-day visits with 0-day procedures should plan for the 2027 reduction now.

MODIFIERS 59 AND XS, WHEN TWO FAMILIES SHARE ONE VISIT

Most dermatology visits need no modifier beyond 25, but two situations need modifier 59 or one of the X modifiers. The first is when premalignant and benign lesions are both destroyed in the same visit: codes 17000 and 17110 are bundled by a National Correct Coding Initiative edit, and modifier 59 shows that the two destruction codes are for distinct lesions and distinct services. The second is when a procedure is performed on a separate lesion or a separate anatomic site from another procedure on the same date. Modifier XS, for a separate structure, is the more specific choice when the separation is anatomic, and modifier 59 is the general distinct procedural service modifier. Do not use 59 or an X modifier to override a bundling edit that cannot be overridden: the biopsy-into-excision rule on the same lesion has no modifier that makes both codes payable, because the biopsy is part of the removal, not a distinct service. For more on how these modifiers differ, see Modifier 59 vs XE, XP, XS and XU. Before appending any modifier, check the edit pair and its modifier indicator, because the indicator, not the documentation alone, decides whether a modifier can split the pair.

WHAT CHANGED FOR 2026

The 2026 code set did not restructure the dermatology families, and the biopsy, excision, destruction and Mohs codes are unchanged, but several changes land on dermatology billing. First, the National Correct Coding Initiative Policy Manual chapter III was revised effective 1 January 2026, and the biopsy-into-removal and one-removal-per-lesion rules above come from that revision. Second, code 10040 was revised for 2026: its descriptor changed from acne surgery to extraction, and it now describes the extraction of multiple milia, comedones, cysts or pustules by marsupialization, opening or removal, with the same 10-day global period. The code is no longer tied to an acne diagnosis, so it can be reported for extraction of those lesions regardless of whether acne is the primary diagnosis. Third, new surface radiation therapy codes 77436 to 77439 replaced deleted code 77401 and Category III code 0394T for superficial and orthovoltage radiation of skin cancers. Code 77436 reports treatment planning and simulation-aided field setting, 77437 reports superficial delivery at 150 kV or less per fraction, 77438 reports orthovoltage delivery above 150 kV through 500 kV per fraction, and add-on code 77439 reports ultrasound image guidance, once per course of treatment rather than once per fraction. Fourth, the 2026 Medicare Physician Fee Schedule conversion factor is 33.40 dollars for clinicians who are not qualifying alternative payment model participants and 33.57 dollars for qualifying participants, national figures before locality adjustment, so the amount actually paid varies by locality and must never be quoted as a local payment figure. Fifth, CMS applied a minus 2.5 percent efficiency adjustment to non-time-based services in 2026, and time-based codes such as evaluation and management codes are exempt, so the adjustment reaches biopsies, destructions, excisions, repairs and Mohs, but not the visit codes. Finally, the American Medical Association CPT 2026 code set carries 418 total changes effective 1 January 2026, including the deletion of the old biopsy codes 11100 and 11101 and the old radiation code 77401, so any superbill still carrying those codes must be updated before it generates another denial.

WORKED EXAMPLE, ALL FIGURES ILLUSTRATIVE

Every figure in this example is illustrative. A patient has three suspicious lesions and a set of actinic keratoses on the forehead. The dermatologist performs a punch biopsy of one lesion on the back, tangential biopsies of two other lesions on the arm, and cryotherapy destruction of 8 actinic keratoses on the forehead. The biopsy lines are reported as one 11104 for the punch biopsy, the highest-ranked technique performed, plus two units of 11103 for the two additional tangential biopsies. The destruction lines are reported as 17000 for the first premalignant lesion plus 7 units of 17003 for lesions two through eight. The destruction stands alongside the biopsies because it is a different set of lesions. In a second example, a benign lesion on the back measures 1.2 cm, and the dermatologist excises it with 0.3 cm margins on each side. The excised diameter is 1.2 cm plus 0.3 cm plus 0.3 cm, which is 1.8 cm, so the code is 11402, benign excision of the trunk, arms or legs, excised diameter 1.1 to 2.0 cm. If the lesion had been measured after removal, formalin shrinkage could have pushed it below 1.1 cm and into the smaller band, so the pre-removal measurement protects the payment. In a third example, a basal cell carcinoma on the nose is treated with Mohs surgery in two stages, with 4 tissue blocks in the first stage and 3 in the second. The claim reports 17311 for the first stage and 17312 for the second, and no separate pathology code, because the microscopic examination is included in the Mohs codes.

COMMON MISTAKES THAT TRIGGER DENIALS

The first common mistake is billing a biopsy with an excision or a destruction of the same lesion, when the biopsy is included in the removal and only the removal is reportable. The second is reporting a primary biopsy code for each technique used on the same date, instead of one primary code for the highest-ranked technique plus add-on codes, or using the add-on codes for multiple samples from the same lesion, when add-ons are only for separate lesions. The third is measuring the excision size after removal, or using the lesion size alone without the margins, which drops the code into the wrong size band. The fourth is billing 17000 and 17110 together without modifier 59, or reporting 17004 together with 17000 and 17003, when 17004 is reported alone for 15 or more premalignant lesions. The fifth is billing a separate pathology code for Mohs tissue examined by the Mohs surgeon, when the pathology work is included in the Mohs code. The sixth is appending modifier 25 to a visit that only documents the procedure discussion and consent, with no separately identifiable evaluation and management work. The seventh is submitting a cosmetic removal to the payer with no medical necessity in the note, or mixing medical and cosmetic lesions on the same claim lines. The eighth is leaving deleted codes on the superbill, including the old biopsy codes 11100 and 11101 and the deleted radiation code 77401, or billing surface radiation therapy with the deleted 77401 instead of the new 77436 to 77439 family. Each of these is preventable by checking four things before the claim goes out: the four facts in the note, the one-removal-code-per-lesion rule, the edit pairs and their modifier indicators, and whether the superbill carries any deleted code.

CHECKLIST

Record the technique, the lesion count, the benign, premalignant or malignant status, and the pre-removal size for every lesion before choosing a code. Report one primary biopsy code per date, for the highest-ranked technique performed, incisional first, then punch, then tangential, with add-on codes only for separate lesions. Choose shave and excision codes by site and by size, and calculate the excised diameter as the lesion plus twice the narrowest margin, measured before the cut. Report premalignant destruction as 17000 plus 17003 for lesions two through fourteen, and 17004 alone for 15 or more, and benign destruction as 17110 for up to 14 lesions and 17111 for 15 or more. Report only one removal code per lesion, and never report a biopsy of the same lesion that was removed at the same encounter. Report Mohs by stage and tissue block, and never bill a separate pathology code for tissue the Mohs surgeon examined. Document the medical reason for every lesion removed, keep medical and cosmetic lesions on separate lines, and charge cosmetic removals to the patient. Append modifier 25 only when the visit is significant and separately identifiable, and do not report G2211 on a visit that carries modifier 25. Append modifier 59 or XS only when the edit pair allows it, and never use a modifier to split a biopsy from a removal of the same lesion. Update the superbill for 2026, removing deleted codes 11100, 11101 and 77401, using the revised 10040 descriptor, and using 77436 to 77439 for surface radiation therapy. Verify the current rule against the CMS manuals and the specific payer policy before acting. For the full denial-code reference, see Claim Denial Codes: Complete Guide.

FREQUENTLY ASKED QUESTIONS

How do I choose between 11102, 11104 and 11106? Choose by technique: 11102 is tangential, 11104 is punch, and 11106 is incisional, each with a matching add-on code for additional lesions. What if I perform two different biopsy techniques on the same date? Report only one primary code, for the highest-ranked technique performed, incisional first, then punch, then tangential, plus add-on codes for the additional lesions. Can I bill a biopsy and an excision of the same lesion? No. The biopsy is included in the removal under the National Correct Coding Initiative Policy Manual chapter III sections E.1 to E.2, revised 1 January 2026, so report the excision only. A biopsy is separately reportable only when it is of a different lesion from the one removed, with each lesion identified separately in the note. How do I size an excision? The excised diameter is the greatest clinical diameter of the lesion plus twice the narrowest margin, measured before the excision. A 1.2 cm lesion with 0.3 cm margins on each side has an excised diameter of 1.8 cm. How do I code destruction of actinic keratoses? For 8 lesions, report 17000 for the first plus 7 units of 17003. For 15 or more, report 17004 alone, with no 17000 and no 17003. When do I use modifier 25 in dermatology? Only when the office visit is significant and separately identifiable from the procedure, with its own documented work beyond the procedure discussion and consent. Do not report G2211 on a visit that carries modifier 25. Is a cosmetic removal ever covered? No. Cosmetic removal is patient-pay, and the note must document the medical reason, such as symptoms, irritation, bleeding, growth or suspicion of malignancy, for a removal to be covered. What changed for dermatology in 2026? Code 10040 was revised from acne surgery to extraction, new surface radiation therapy codes 77436 to 77439 replaced deleted code 77401 and Category III code 0394T, and a minus 2.5 percent efficiency adjustment applies to non-time-based services but not to time-based evaluation and management codes.

A note on codes and coverage: This article is educational information about medical billing rules, not legal, financial or compliance advice. Codes, coverage rules and payer policies vary and change over time, so always verify the current rule against the CMS manuals and the specific payer policy before acting. The worked example uses illustrative figures only. The 2026 conversion factor figures of 33.40 dollars and 33.57 dollars are national figures before locality adjustment. The biopsy hierarchy, the one-removal-code-per-lesion rule and the biopsy-into-removal bundling were verified against the Medicare National Correct Coding Initiative Policy Manual chapter III, revised 1 January 2026, and the 2026 changes for 10040 and the 77436 to 77439 family were verified against the American Medical Association CPT 2026 code set.

Having trouble with dermatology billing, or with biopsy, destruction, excision or Mohs denials? Neximed Billing provides denial management, corrected claim review and billing workflow support. Contact us at info@neximedbilling.com or +1-406-2251570.

Related reading: Modifier 25 Denial Appeal · Modifier 59 vs XE, XP, XS and XU · Claim Denial Codes: Complete Guide